Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer

Gynecologic Oncology

Volumn 69, Issue 1, 1998, Pages 23-31

  Zheng, Wenxin ^a,d   Luo, Michelle P ^a   Welt, Corrine ^a   Lambert Messerlian, Geralyn ^b   Sung, C James ^b   Zhang, Zhong ^c   Ying, Shao Yao ^c   Schneyer, Alan L ^a   Lauchlan, Stuart C ^b   Felix, Juan C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; INHIBIN; RECEPTOR SUBTYPE;

ALPHA CHAIN; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032054077     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.4958     Document Type: Article

References (44)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Xlin 65:5-27, 1996
2. Piver MS, Baker TR, Piedmante M, Sandecki AM: Epidemiology and etiology of ovarian cancer. Semin Oncol 18:177-185, 1991
3. Hamilton TC: Ovarian cancer. I. Biology. Curr Probl Cancer 16:1-57, 1992
4. Simon WE, Albrecht M, Hansel M, Dietel M, Holzel F: Cell lines dereived from ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 70:839-844, 1983
5. Zheng W, Magid MS, Kramer EE, Chen YT: Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 148:47-53, 1996
6. Jindal SK, Snoey DM, Lobb DK, Dorrington JH: Transforming growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol Oncol 53:17-23, 1994
7. Jindal SK, Ishii E, Letarte M, Vera S, Teerds S, Dorrington JH: Regulation of TGF alpha gene expression in a human surface epithelial cell line. Biol Reprod 52:1027-1037, 1995
8. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin SP, Spiess J, Rivier J: Chemical and biochemical characterization of the inhibin family protein hormones. Rec Prog Horm Res 44:1-34, 1988
9. Ying S-Y: Inhibins, activins, and follistatin: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267-293, 1988
10. DeKretser DM, Robertson DM: The isolation and physiology of inhibin and related proteins. Biol Reprod 40:33-47, 1989
11. Ying S-Y, Zhang Z, Furst B, Batres Y, Huang G, Li G: Activins and activin receptors in cell growth. Proc Soc Exp Biol Med 214:114-122, 1997
12. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey NM, Gash DJ, Chow EP, Fisher RA, Bertonis JM, Torres G, Wallner BP, Ramachandran KL, Ragin RC, Manganaro TF, MacLaughlin DT, Donahoe PK: Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the gene in animal cells. Cell 45:686-694, 1986
13. Findlay JK: An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 48:15-23, 1993
14. Matzuk MM, Finegold MJ, Su JJ, Hsueh AJW, Bradley A: Alpha-inhibin is a tumor-suppressor gene with gonadal specialty in mice. Nature 360: 313-319, 1992
15. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ: Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Rec Prog Horm Res 51:123-157, 1996
16. DiSimone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL: Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 137:486-494, 1996
17. Zheng W, Sung CJ, Hanna I, Lambert-Messerlian G, Steinhoff M, Lauchlan SC: α and β subunits of inhibin/activin as markers for gonadal sex-cord stromal differentiation. Int J Gynecol Pathol 16:263-271, 1997
18. Kruk PA, Maines-Bandira SL, Auersperg N: A simplified method to culture human ovarian surface epithelium. Lab Invest 63:132-136, 1990
19. Ying S-Y, Zhang Z, Xing W: Expression of activin and activin receptors in PC3 human prostatic cancer cells. Int J Oncol 6:601-606, 1995
20. Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF: Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically. Endocrinology 137:240-247, 1996
21. Shoham Z: Epidemiology, etiology and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril 62:433-448, 1994
22. Shikone T, Matzuk M, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hsueh AJ: Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the roel of activin as an autocrine growth factor. Mol Endocrinol 8:983-985, 1994
23. Cramer DW, Welch WR: Determinants of ovarian cancer risk. II. Influences regarding pathogenesis. J Natl Cancer Inst 71:717-721, 1983
24. McCluskey L, Dubeau L: Biology of ovarian cancer. Curr Opin Oncol 9:465-470, 1997
25. Scully RE. Pathology of ovarian cancer precursors. J Cell Biochem 23: 208S-218S, 1995
26. Welt CK, Lambert-Messerlian G, Zheng W, Sluss P, Crowley WF, Schneyer AL: Activin, inhibin and follistatin in epithelial ovarian carcinoma. J Clin Endocrinol Metab 82:3720-3727, 1997
27. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG: Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 57:27-32, 1995
28. Healy DL, Burger HG, Mamer P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ: Elevated serum inhibin concentrations in posmenopausal women with ovarian tumors. N Engl J Med 329:1539-1542, 1993
29. Burger HG, Robertson DM, Cahir N, Mamers P, Healy DL, Jobling T, Groome N: Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clin Endocrinol 44:413-418, 1996
30. Burger HG, Fuller PJ: The inhibin/activin family in ovarian cancer. Trends Endocrinol Metab 7:197-202, 1996
31. Lambert-Messerlian G, Steinhoff M, Zheng W, Canick J, Seifer D, Schneyer A: Characterization of immunoreactive forms of inhibin in serum of pre- and post-menopausal women with epithelial ovarian cancer. Gynecol Oncol 65:512-516, 1997
32. Blaakaer J, Micic S, Morris ID, Hording U, Nennett P, Toftager-larsen K, Djursing H, Bock JE: Immunoreactive inhibi-production in post-menopausal women with malignant epithelial ovarian tumors. Eur J Obstet Gynecol Reprod Biol 52:105-110, 1993
33. Blaakaer J, Micic S, Toftager-larsen K, Hording U, Bock JE, Lebech PE: The post-operative gonadotropin level in post-menopausal women with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 52:111-116, 1993
34. Biskind MS, Biskind GS: Development of tumors in the rat ovary after transplantation into the spleen. Proc Soc Exp Bio Med 55:176-179, 1944
35. Stadel BV: The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 123:772-774, 1975
36. Cramer DW, Welch WR: Determinants of ovarian cancer risk. II. Influences regarding pathogenesis. J Natl Cancer Inst 71:717-721, 1983
37. Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies, IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol 136:1212-1220, 1992
38. Wimalasena J, Dostal R, Meehan D: Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 46:345-350, 1992
39. Coerver KA, Woodruff TK, Finegold MJ, Mather J, Bradley A, Matzuk MM: Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol Endocrinol 10:534-543, 1996
40. Kumar TR, Wang Y, Matzuk MM: Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology 137:4210-4216, 1996
41. Mayo KE, Cerelli GM, Spiess J, Rivier J, Rosenfeld MG, Evans RM, Vale W: Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci USA 83:5849-5853, 1986
42. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H, Seeburg PH: Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318:659-663, 1985
43. Matsuzaki K, Xu J, Wang F: A widely expressed transmembrane serine/ threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenic factor. J Biol Chem 268:12719-12723, 1993
44. Donaldson CJ, Mathews LS, Vale WW: Molecular cloning and binding properties of the human type II activin receptor. Biochem Biophys Res Commun 184:310-316, 1992